Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas

Journal: Nature Communications

Published: 2020-02-18

DOI: 10.1038/s41467-020-14642-0

Affiliations: 18

Authors: 35

Go to article
Institutions Share
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.27
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.25
German Consortium of Translational Cancer Research (DKTK), Germany 0.19
University Medical Centre Mannheim (UMM) at Medical Faculty Mannheim, Uni Heidelberg, Germany 0.12
University of Zurich (UZH), Switzerland 0.11
Heidelberg University (Uni Heidelberg), Germany 0.04
National Center for Tumor Diseases (NCT) Heidelberg, Germany 0.01
Helmholtz Institute for Translational Oncology Mainz (HI-TRON Mainz), Germany 0.01
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER